Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Androgel Class Action Lawsuit Filed Against AbbVie, Abbott in Canada July 25, 2014 Irvin Jackson Add Your Comments Abbott Laboratories and AbbVie face a new class action lawsuit over Androgel in Canada, raising allegations similar to those brought in dozens of cases filed in the United States over side effects of testosterone therapy. The case was filed late last month on behalf of all Androgel users in Canada, indicating that the drug makers withheld warnings about the risk of heart attacks, strokes and other injuries associated with the popular testosterone gel. The Androgel class action indicates that instead of properly disclosing important safety information to Canadians, the pharmaceutical companies aggressively marketed the drug and mislead the public about the extent of men who may require prescription treatments for low testosterone to maximize profits. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to a press release issued by the law firms that filed the case, it is believed to be the first lawsuit brought in Canada over problems with testosterone replacement therapy. However, a similar class action was filed in Canada this month over Delatestryl testosterone injections. Androgel Heart Risks AbbVie and Abbott face a number of similar Androgel lawsuits in the United States, which have been brought on behalf of individuals nationwide who suffered a heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism or sudden death after using the treatment to combat symptoms associated with drops in testosterone levels. On July 15, Health Canada, that nation’s medical device and drug agency, warned that country’s residents that the side effects of Androgel and other similar drugs can increase the risk of cardiovascular problems, indicating that there is a “growing body of evidence” linking testosterone and heart risks. Data reviewed by the agency showed that many of the men who began having cardiovascular problems after using the drugs had those issues dissipate when they stopped using testosterone. The issues then often returned when they began using it again, which provides strong evidence of a causal link. The determination and new label changes in Canada came after a safety review of all testosterone adverse event reports and medical literature. In the United States, the FDA announced a similar investigation into the potential risk testosterone heart problems in January 2014, following a series of studies published late last year and early this year that raised concerns about the safety of the medication. A study published by the Journal of the American Medical Association (JAMA) in November 2013 found that side effects of low testosterone drugs were associated with increased rates of heart attacks, strokes, and death among veterans with pre-existing heart conditions. That research was followed by a larger study published in the medical journal PLOSOne in January 2014, which involved a review of data on more than 55,000 men who received an initial prescription for testosterone and compared them to men who received a first prescription for an erectile dysfunction drug. The study found that low T treatments may double the risk of heart attack for younger men with pre-existing heart disease, and for men over the age of 65, regardless of their prior heart conditions. While testosterone litigation is just getting underway in Canada, in the U.S, more than 150 lawsuits over Androgel and other drugs have been centralized in a multidistrict litigation (MDL) in U.S. District Court for the Northern District of Illinois, where the cases will be managed during pretrial proceedings in a manner similar to an Androgel class action. However, each claim remains an individual lawsuit where the plaintiff must establish that their injury was caused by a failure to warn about the risks associated with the medication. Tags: Abbott Laboratories, AbbVie, AndroGel, Delatestryl, Endo Pharmaceuticals, Testosterone Gel, Testosterone Shot More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 1 Comments Lanny October 18, 2014 i have been using this product for a few years I have had chest pain after using it I stopped for a few days and then used it again the heart pain came back again. I am waiting to see my Dr. And will post again later Lanny d. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: today) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: yesterday) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025) Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 4 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: today) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: yesterday) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 4 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)